Neok Bio is a biotech startup that focuses on bispecific ADCs in cancer therapy.
Neok Bio has raised $75.0M in total funding. The most recent round was Series A. The last funding was announced in November 2025.
Neok Bio's investors include ABL Bio.
Neok Bio is headquartered in Palo Alto, United States.
Neok Bio is a biotech startup that focuses on bispecific ADCs in cancer therapy.
Neok Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neok Bio — Funding & Investors." VCBacked, November 4, 2025, https://www.vcbacked.co/company/neok-bio. Accessed July 31, 2026.
VCBacked. (2025). Neok Bio — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/neok-bio
{{cite web |title=Neok Bio — Funding & Investors |url=https://www.vcbacked.co/company/neok-bio |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated